| Structure |
Chemical Name |
CAS |
MF |
 |
Gadobutrol Impurity 3 |
2227984-48-5 |
|
 |
2,4,6-トリプロピル-1,3,5-トリオキサン |
2396-43-2 |
C12H24O3 |
 |
Timolol maleate impurity 02 |
|
|
 |
Piracetam IMPURITY |
|
|
 |
Paroxetine Impurity 45 |
1396174-70-1 |
C19H20FNO3 |
 |
Oseltamivir Impurity 101 |
|
|
 |
(trans)-4-((2-amino-4,6-dibromobenzyl)amino)cyclohexanol |
|
C13H18Br2N2O |
 |
(1R,4S)-4-アミノ-2-シクロペンテン-1-カルボン酸メチル |
352226-74-5 |
C7H11NO2 |
 |
Lenvatinib impurity LFZZ-18 |
|
C11H8Cl2N2O2 |
 |
AtracuriuM IMpurity C1 (trans-Monoacrylate) |
|
|
 |
N-Butyl Nor ScopolaMine Hydrochloride |
22235-98-9 |
C20H28ClNO4 |
 |
N-(2-Chloro-ethyl)-N'-(2,3-dichloro-phenyl)-ethane-1,2-diamine |
|
C10H13Cl3N2 |
 |
Peramivir Impurity 20 |
|
|
 |
Nirmatrelvir Impurity 10 |
|
|
 |
EP Impurity Catalog |
|
|
 |
4-フェニルモルホリン-3-オン |
29518-11-4 |
C10H11NO2 |
 |
4-Thiazoleacetyl chloride, 2-amino-, monohydrochloride
|
66313-72-2 |
C5H6Cl2N2OS |
![2-[(1-Benzylpiperidin-4-yl)hydroxyMethyl]-5,6-diMethoxyindan-1-one](/CAS/GIF/197010-20-1.gif) |
2-[(1-Benzylpiperidin-4-yl)hydroxyMethyl]-5,6-diMethoxyindan-1-one |
197010-20-1 |
C24H29NO4 |
 |
Butyphthalide impurity 44 |
952413-01-3 |
C13H18O3 |
![Morpholine, 4-[4-(1,1-dimethylethoxy)-1,2,5-thiadiazol-3-yl]-](/CAS/20210305/GIF/158636-99-8.gif) |
Morpholine, 4-[4-(1,1-dimethylethoxy)-1,2,5-thiadiazol-3-yl]- |
158636-99-8 |
C10H17N3O2S |
 |
AMisulpride IMpurity |
84859-26-7 |
C8H17NO2 |
 |
Palbociclib Impurity 67 |
|
|
 |
N-(4-メチルピリジン-3-イル)カルバミン酸メチル |
694495-63-1 |
C8H10N2O2 |
![Apixaban impurity 14/6-(4-aminophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid](/CAS/20200611/GIF/1704504-93-7.gif) |
Apixaban impurity 14/6-(4-aminophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid |
1704504-93-7 |
C20H18N4O4 |
 |
Peramivir Intermediate Impurity 37 |
|
|
 |
Ceftazidime Sulfoxide Impurity |
|
|
![N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine](/CAS/20180629/GIF/1092578-45-4.gif) |
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
1092578-45-4 |
C20H25N5 |
![Hexanamide, N-[(1S)-1-(aminocarbonyl)propyl]-3-(hydroxymethyl)-, (3R)-](/CAS/20210305/GIF/2252417-17-5.gif) |
Hexanamide, N-[(1S)-1-(aminocarbonyl)propyl]-3-(hydroxymethyl)-, (3R)- |
2252417-17-5 |
C11H22N2O3 |
 |
Istradefylline impurity B |
|
|
 |
Ozagrel-015 |
1332370-00-9 |
C10H10O3 |
![IMp. A (EP): Ethyl 4-[(11RS)-8-Chloro-11-hydroxy-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]piperidine-1-carboxylate](/CAS/20200611/GIF/38092-95-4.gif) |
IMp. A (EP): Ethyl 4-[(11RS)-8-Chloro-11-hydroxy-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]piperidine-1-carboxylate |
38092-95-4 |
C19H20N2 |
 |
Linagliptin Impurity 44 |
|
|
 |
Cefradine Impurity 8 |
30959-67-2 |
C16H19N3O4S |
 |
Fudosteine Impurity 2 |
1480319-53-6 |
C6H13NO5S |
 |
Brexpiprazole Impurity 34 |
2247155-42-4 |
C25H27N3O4S |
 |
Ornidazole Impurity 26 |
|
|
 |
rac Deoxy-O-desMethyl Venlafaxine |
1346605-18-2 |
C16H25NO |
 |
Peramivir Impurity 25 |
|
|
 |
GINKGOLIC ACIDS |
|
|
 |
Flucloxacillin Impurity B |
|
|
 |
Olsalazine Impurity F |
|
|
 |
ZIDOVUDINE IMPURITY B |
|
|
 |
(S)-N-((S)-1-amino-1-oxobutan-2-yl)-3-(bromomethyl)hexanamide |
|
|
 |
Empagliflozin Impurity 61 |
|
|
 |
Pitavastatin Impurity 72 |
|
|
 |
6-methyl-2-oxo-5-pyridin-2-yl-1H-pyridine-3-carbonitrile |
106637-42-7 |
C12H9N3O |
 |
Irinotecan EP Impurity H |
|
|
 |
Budesonide Impurity 6 |
131918-73-5 |
C21H26O6 |
 |
Olprinone Impurity 8 |
|
|
 |
Dolutegravir Impurity 19 |
|
|
 |
Ritonavir EP Impurity I |
165315-26-4 |
C36H46N6O5S2 |
 |
1-ブタンスルホン酸メチル |
2374-69-8 |
C5H12O3S |
 |
3-(3-Chloropropyl)-7,8-dimethoxy-2,3,4,5-tetrahydro-1H-3-benzazepin-2-one |
85175-65-1 |
C15H20ClNO3 |
 |
N-((4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)phenyl) sulfonyl)acetamide |
198471-47-5 |
C19H16F3N3O3S |
 |
Nsc529487 |
3310-47-2 |
C9H13N3O6 |
 |
Pregna-1,4-dien-3-one, 21-(acetyloxy)-11,17,20-trihydroxy-6-methyl-, (6α,11β)- (9CI) |
151003-82-6 |
C24H34O6 |
 |
Benzenesulfonamide, 2-(5-methyl-3-phenyl-4-isoxazolyl)- |
2304623-35-4 |
C16H14N2O3S |
![N-formyl-1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide](/CAS/20180703/GIF/1351611-14-7.gif) |
N-formyl-1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide |
1351611-14-7 |
C26H25N5O5 |
 |
2-メトキシ-5-スルホ安息香酸1-メチル |
94134-07-3 |
C9H10O6S |
 |
Pidotimod Impurity O |
|
|
 |
Labetalol EP impurity E |
|
|
 |
Cisatracurium besylate impurity11 |
|
|
 |
Ropivacaine-cycle |
1945965-95-6 |
C17H24N2O |
 |
Cabozantinib impurity 40 |
|
|
 |
EMpagliflozin iMpurity 11 |
|
|
 |
pranoprofen impurity 25 |
|
|
 |
Metoprolol IMpurity 4 |
|
C15H25NO3 |
 |
PD 312237 |
501666-23-5 |
C20H35NO11 |
 |
Teneligliptin Impurity 3 |
|
|
 |
Pazopanib ImpurityABCDEFGHJKL |
|
|
 |
Dasatinib IMpurity 6 |
|
|
 |
2-cyano-1,3-bis(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine |
55272-86-1 |
C16H24N8S2 |
 |
Sofosbuvir Impurity 9 |
|
|
 |
Vortioxetine Impurity 29 |
1928741-88-1 |
C18H23ClN2S |
 |
1',15-オキシエリスロマイシン |
41451-91-6 |
C37H65NO14 |
 |
N-エチル-N-ニトロソ-2-プロパンアミン |
16339-04-1 |
C5H12N2O |
![Thiophene, 2-(2-fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]-](/CAS/20210305/GIF/2436275-33-9.gif) |
Thiophene, 2-(2-fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]- |
2436275-33-9 |
C18H14FIS |
 |
1-Pyrrolidinecarboxylic acid, 4-hydroxy-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4S)- |
401564-34-9 |
C13H22N2O4S |
![N-[(10S)-3,4,5,14-テトラメトキシ-13-オキソトリシクロ[9.5.0.02,7]ヘキサデカ-1(16),2(7),3,5,11,14-ヘキサエン-10-イル]ホルムアミド](/CAS/GIF/7411-12-3.gif) |
N-[(10S)-3,4,5,14-テトラメトキシ-13-オキソトリシクロ[9.5.0.02,7]ヘキサデカ-1(16),2(7),3,5,11,14-ヘキサエン-10-イル]ホルムアミド |
7411-12-3 |
C21H23NO6 |
![1-(4,8-bis-(2,2,2-trifluoroacetyl)-11-{4-[4,8,11-tris-(2,2,2-trifluoroacetyl)-1,4,8,11-tetraazacyclotetradec-1-ylMethyl]-benzyl}-1,4,8,11-tetraazacyclotetradec-1-yl)-2,2,2-trifluoroethanone](/CAS/GIF/406939-93-3.gif) |
1-(4,8-bis-(2,2,2-trifluoroacetyl)-11-{4-[4,8,11-tris-(2,2,2-trifluoroacetyl)-1,4,8,11-tetraazacyclotetradec-1-ylMethyl]-benzyl}-1,4,8,11-tetraazacyclotetradec-1-yl)-2,2,2-trifluoroethanone |
406939-93-3 |
C40H48F18N8O6 |
![methyl3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin -4-yl)amino)piperidin-1-yl)-3-oxopropanoate](/CAS/20180601/GIF/1616761-01-3.gif) |
methyl3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin -4-yl)amino)piperidin-1-yl)-3-oxopropanoate |
1616761-01-3 |
C17H23N5O3 |
 |
Pramipexole Impurity 55 |
959012-83-0 |
C8H11NO2 |
 |
Indacaterol Impurity 7 |
1403389-05-8 |
C24H30N2O3 |
![(2S)-Pinocembrin 7-O-[2''-O-(5'''-O-trans
-cinnamoyl)-β-D-apiofuranosyl]-β-D-glucoside](/CAS/20210111/GIF/773899-29-9.gif) |
(2S)-Pinocembrin 7-O-[2''-O-(5'''-O-trans
-cinnamoyl)-β-D-apiofuranosyl]-β-D-glucoside |
773899-29-9 |
C35H36O14 |
 |
3-Oxo Citalopram |
372941-54-3 |
C20H19FN2O2 |
 |
Rotigotine Impurity 2 |
|
|
 |
Flomoxef oxidation impurities |
|
|
![(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoic acid](/CAS/20150408/GIF/1039307-95-3.gif) |
(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoic acid |
1039307-95-3 |
C18H21NO2 |
 |
Febuxostat Impurity 54 |
|
|
 |
Febuxostat Impurity 82 |
|
|
 |
Salbutamol Impurity 37 |
|
|
 |
LaMotrigine IMpurity |
|
|
 |
Bortezomib Impurity 16 |
|
|
 |
L-アラニン2-(2-アミノ-6-オキソ-1,6-ジヒドロ-9H-プリン-9-イルメトキシ)エチル |
84499-64-9 |
C11H16N6O4 |
 |
Olprinone Impurity C |
|
|
![4-AMino-N-[(1-ethyl-2-pyrrolidinyl)Methyl]-5-(ethylsulfonyl)- 2-MethoxybenzaMide N-Oxide](/CAS/GIF/71676-01-2.gif) |
4-AMino-N-[(1-ethyl-2-pyrrolidinyl)Methyl]-5-(ethylsulfonyl)- 2-MethoxybenzaMide N-Oxide |
71676-01-2 |
C17H27N3O5S |
 |
Moxifloxacin Impurity 45 |
|
|
 |
4-Acetyl Rhein |
875535-36-7 |
C17H10O7 |
 |
Regorafenib Impurity 10 |
|
|
![1-NaphthaleneMethanaMine, 7,8-dihydro-α-Methyl-N-[3-[3-(trifluoroMethyl)phenyl]propyl]-, hydrochloride (1:1), (αR)-](/CAS/20180808/GIF/1020414-33-8.gif) |
1-NaphthaleneMethanaMine, 7,8-dihydro-α-Methyl-N-[3-[3-(trifluoroMethyl)phenyl]propyl]-, hydrochloride (1:1), (αR)- |
1020414-33-8 |
C22H25ClF3N |